Original Research
Published on 23 Jul 2021
Reynoutrin Improves Ischemic Heart Failure in Rats Via Targeting S100A1
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.703962
- 2,620 views
- 11 citations
Type at least 3 characters
1,205 articles
Articles
Original Research
Published on 22 Jul 2021
Neferine Ameliorates Sepsis-Induced Myocardial Dysfunction Through Anti-Apoptotic and Antioxidative Effects by Regulating the PI3K/AKT/mTOR Signaling Pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.706251
- 7,648 views
- 42 citations
Original Research
Published on 19 Jul 2021
Targeting Glycogen Synthase Kinase 3 Beta Regulates CD47 Expression After Myocardial Infarction in Rats via the NF-κB Signaling Pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.662726
- 2,985 views
- 7 citations
Original Research
Published on 19 Jul 2021
A Single, Acute Astragaloside IV Therapy Protects Cardiomyocyte Through Attenuating Superoxide Anion-Mediated Accumulation of Autophagosomes in Myocardial Ischemia-Reperfusion Injury
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.642925
- 3,162 views
- 15 citations
Original Research
Published on 15 Jul 2021
Bibliometric and Visual Analysis of Vascular Calcification Research
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.690392
- 5,676 views
- 33 citations
Original Research
Published on 15 Jul 2021
LncRNA Chaer Prevents Cardiomyocyte Apoptosis From Acute Myocardial Infarction Through AMPK Activation
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.649398
- 2,922 views
- 10 citations
Original Research
Published on 14 Jul 2021
Investigating the Pharmacological Mechanisms of SheXiang XinTongNing Against Coronary Heart Disease Based on Network Pharmacology and Experimental Evaluation
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.698981
- 3,847 views
- 9 citations
Review
Published on 13 Jul 2021
Research Progress on Catalpol as Treatment for Atherosclerosis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.716125
- 7,132 views
- 20 citations
Original Research
Published on 12 Jul 2021
A SGLT2 Inhibitor Dapagliflozin Alleviates Diabetic Cardiomyopathy by Suppressing High Glucose-Induced Oxidative Stress in vivo and in vitro
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.708177
- 7,571 views
- 48 citations
Review
Published on 08 Jul 2021
Electrical Features of the Diabetic Myocardium. Arrhythmic and Cardiovascular Safety Considerations in Diabetes
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.687256
- 8,142 views
- 29 citations
Original Research
Published on 07 Jul 2021
Geniposide Combined With Notoginsenoside R1 Attenuates Inflammation and Apoptosis in Atherosclerosis via the AMPK/mTOR/Nrf2 Signaling Pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.687394
- 5,306 views
- 39 citations
Original Research
Published on 02 Jul 2021
Il12a Deletion Aggravates Sepsis-Induced Cardiac Dysfunction by Regulating Macrophage Polarization
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.632912
- 5,444 views
- 24 citations
Review
Published on 02 Jul 2021
Potential Role of Protein Kinase C in the Pathophysiology of Diabetes-Associated Atherosclerosis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.716332
- 14,322 views
- 47 citations
Original Research
Published on 28 Jun 2021
Therapeutic Impact of Costus (Saussurea lappa) Against Ehrlich Solid Tumor-Induced Cardiac Toxicity and DNA Damage in Female Mice
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.708785
- 7,432 views
- 16 citations
Original Research
Published on 24 Jun 2021
MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.680349
- 2,871 views
- 13 citations
Original Research
Published on 24 Jun 2021
SGLT1 Knockdown Attenuates Cardiac Fibroblast Activation in Diabetic Cardiac Fibrosis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2021.700366
- 4,189 views
- 16 citations